The company will use the funds to commercialize a biomarker for colon cancer. Applied Proteomics’ system looks at activity patterns in the proteins encoded by a person’s genome rather than just the genome alone to detect early signs of cancer.
The $28 million contribution came from Genting Berhad, an investment holding company in Malaysia, as well as existing investors.
More Articles on Gastroenterology:
Vice & Associates Clinical Research Expands Gastroenterology Suite, Team Members
Drs. Rayees Nizam, Thomas Lee Join Associated Gastroenterologists of Central New York
5 Recent GI-Driven Center Openings & Plans
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
